查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1495443

氟二酮市场：按纯度、应用和最终用户 - 2024-2030 年全球预测

Fluindione Market by Purity (95%, >= 98%), Application (Anticoagulating Treatment, Permanent Atrial Fibrillation, Pulmonary Embolism), End-User - Global Forecast 2024-2030
出版日期: | 出版商: 360iResearch | 英文 181 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计2023年Fluindione市场规模为9.199亿美元，预计2024年将达到9.7151亿美元，2030年将达到13.5551亿美元，复合年增长率为5.69%。

氟二酮市场是指主要集中在氟二酮的生产、分销和应用的全球产业格局，氟二酮是一种用于治疗和预防血栓栓塞性疾病的口服抗凝血剂。该市场包括製药公司、医疗保健提供者、研究机构和需要抗凝血治疗的患者。传统上，氟二酮在临床环境中用于预防和控制患者的血栓症和栓塞。其应用也扩展到需要长期抗凝血治疗的患者，例如心房颤动、静脉血栓栓塞症以及血栓形成高风险的患者。氟吲二酮市场的成长受到心血管疾病盛行率上升、医学研究的进步、全球医疗基础设施的改善和扩展以及对血栓性栓塞症的认识不断提高等因素的影响。然而，由于氟二酮的潜在副作用，包括出血风险和药物交互作用，市场面临限制。监管挑战、严格的核准流程以及新抗凝血剂的竞争是主要障碍。此外，患者对长期抗凝血治疗的依从性仍是一个挑战。同时，氟二酮扩张的机会在于开发具有更高功效和安全性的氟二酮衍生物、製药公司与研究机构之间的战略联盟以及全球新型药物输送系统的持续开发。

主要市场统计
基准年[2023] 9.199 亿美元
预测年份 [2024] 97151万美元
预测年份 [2030] 1,355.51 百万美元
复合年增长率（%） 5.69%

区域洞察

在北美，尤其是在美国，心血管疾病的盛行率正在增加，导致对抗凝剂的巨大需求。美国消费者的行为深受临床医师建议的影响，并且越来越青睐副作用较少、患者预后较好的药物。两国的研究都很活跃，每年都有大量的专利申请，这显示两国的技术创新活跃，竞争环境良好。由于医疗基础设施的改善以及人们对需要抗凝血治疗的疾病的认识不断提高，南美市场呈现适度增长。由于完善的医疗保健系统和对血栓栓塞性疾病的高度认识，欧洲国家传统上一直是氟二酮的强劲市场。尤其是法国，在氟二酮市场占有重要地位，并采取了研究和开发倡议。中东和非洲是多元化的，海湾国家由于医疗保健投资的增加和更容易获得的医疗保健服务而显示出市场扩张的潜力。然而，儘管非洲对抗凝血药物的需求庞大，但非洲在卫生基础设施和取得药物方面仍面临挑战。在亚太地区，中国和印度不断提高的医疗意识和不断上涨的医疗成本推动了对氟啶酮的需求。日本拥有完善的医疗体系，在强劲的研发活动的支持下，对氟二酮的需求稳定。最近对卫生基础设施的投资以及对心血管疾病日益增长的兴趣是该地区的主要驱动力。

FPNV定位矩阵

FPNV 定位矩阵对于评估供应商在全印度酮市场的定位至关重要。此矩阵提供了对供应商的全面评估，并检验了与业务策略和产品满意度相关的关键指标。这种详细的评估使用户能够根据自己的要求做出明智的决定。根据评估结果，供应商被分为代表其成功程度的四个像限：前沿（F）、探路者（P）、利基（N）和重要（V）。

市场占有率分析

市场占有率分析是一种综合工具，可对 Full Indion 市场中供应商的当前状态进行深入而详细的评估。透过仔细比较和分析供应商的贡献，您可以更深入地了解每个供应商的绩效以及他们在争夺市场占有率时面临的挑战。这些贡献包括整体收益、客户群和其他关键指标。此外，该分析还提供了对该细分市场竞争力的宝贵见解，包括研究基准年期间观察到的累积、分散主导地位和合併特征等因素。有了这些详细信息，供应商可以做出更明智的决策并製定有效的策略，以在市场竞争中保持领先地位。

策略分析与建议

策略分析对于寻求在全球市场站稳脚跟的组织至关重要。对氟二酮市场当前地位的全面评估使公司能够做出符合其长期愿望的明智决策。此关键评估涉及对组织的资源、能力和整体绩效进行彻底分析，以确定核心优势和需要改进的领域。

目录

第一章 前言

第二章调查方法

第三章执行概述

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 需要抗凝血治疗的病例增加
      • 改善并扩大全球医疗基础设施
    • 抑制因素
      • 对副作用和与其他药物相互作用的担忧
    • 机会
      • 世界各地正在开发新的药物输送系统
      • 氟二酮进一步治疗应用的研究
    • 任务
      • 严格的药品核准监理流程
  • 市场区隔分析
    • 纯度：全茚酮的纯度优选 >98%，以满足活性药物成分 (API) 的严格要求
    • 应用：扩大氟二酮在抗凝血治疗的应用
  • 市场扰动分析
  • 波特五力分析
  • 价值炼和关键路径分析
  • 价格分析
  • 技术分析
  • 专利分析
  • 贸易分析
  • 法规结构分析

第六章氟二酮市场：依纯度

  • 介绍
  • 95%
  • 98%以上

第七章完整的印度酮市场：依应用分类

  • 介绍
  • 抗凝血治疗
  • 持续性心房颤动
  • 肺动脉栓塞
  • 静脉血栓症

第 8 章完整的 Indion 市场：依最终使用者分类

  • 介绍
  • 医院/诊所
  • 长期照护设施

第九章 美洲完整的印度酮市场

  • 介绍
  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第10章亚太全印度市场

  • 介绍
  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十一章 欧洲、中东和非洲完整的印度酮市场

  • 介绍
  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十二章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
    • Helixomer 获得 NIH 200 万美元津贴用于开发抗凝血剂
  • 战略分析和建议

第13章竞争产品组合

  • 主要企业简介
  • 主要产品系列
Product Code: MRR-757B1C9CB035

[181 Pages Report] The Fluindione Market size was estimated at USD 919.90 million in 2023 and expected to reach USD 971.51 million in 2024, at a CAGR 5.69% to reach USD 1,355.51 million by 2030.

The fluindione market refers to the global industry landscape focused on the production, distribution, and application of Fluindione, an oral anticoagulant used primarily in treating and preventing thromboembolic diseases. This market encompasses pharmaceutical companies, healthcare providers, research institutions, and patients requiring anticoagulant therapy. Fluindione is conventionally used in clinical settings for preventing and managing thrombosis and embolism in patients. Its applications extend to patients requiring long-term anticoagulant therapy, such as those with atrial fibrillation, venous thromboembolism, and individuals at a high risk of forming blood clots. Growth in the fluindione market is influenced by factors, including the elevating prevalence of cardiovascular diseases, advancements in medical research, improvements and expansions in the global healthcare infrastructure, and greater awareness of thromboembolic diseases. However, the market faces limitations due to the potential side effects of Fluindione, such as bleeding risks and drug interactions. Regulatory challenges, stringent approval processes, and competition from newer anticoagulants pose significant hurdles. Additionally, patient compliance with long-term anticoagulant therapy remains a challenge. On the other hand, opportunities for the expansion of fluindione lie in the development of fluindione derivatives with improved efficacy and safety profiles, strategic collaborations between pharmaceutical companies and research institutions, and the Ongoing development of novel drug delivery systems globally.

KEY MARKET STATISTICS
Base Year [2023] USD 919.90 million
Estimated Year [2024] USD 971.51 million
Forecast Year [2030] USD 1,355.51 million
CAGR (%) 5.69%

Regional Insights

In North America, the US, in particular, has an increased prevalence of cardiovascular disorders, contributing to a substantial need for anticoagulants. Customer behavior in the US is strongly influenced by clinician recommendations, with a growing preference for drugs having fewer side effects and better patient outcomes. Both countries exhibit a robust research landscape, with numerous patents filed yearly, indicating vigorous innovation and a competitive market environment. The South American market is marked by gradual growth attributed to improving healthcare infrastructure and increasing awareness about conditions necessitating anticoagulation therapy. European countries have traditionally been strong markets for fluindione, attributed to well-established healthcare systems and high awareness regarding thromboembolic diseases. France, in particular, has a notable presence in the fluindione market with research and development initiatives. The Middle East and Africa present a varied landscape, with the Gulf countries showing potential for market expansion due to increasing healthcare investment and more accessible healthcare services. However, Africa faces challenges related to healthcare infrastructure and access to medications despite a noticeable need for anticoagulants. In APAC, rising healthcare awareness and increased healthcare expenditures in China and India drive the demand for fluindione. Japan, with its sophisticated healthcare system, shows a steady demand for fluindione, supported by robust research and development activities. Recent investments in healthcare infrastructure and a growing focus on cardiovascular diseases are key drivers in this region.

Market Insights

  • Market Dynamics

The market dynamics represent an ever-changing landscape of the Fluindione Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.

    • Market Drivers
      • Rising cases of conditions requiring anticoagulation therapy
      • Improvements and expansions in the global healthcare infrastructure
    • Market Restraints
      • Concerns related to adverse effects and interactions with other medications
    • Market Opportunities
      • Ongoing development of novel drug delivery systems globally
      • Research into additional therapeutic applications of fluindione
    • Market Challenges
      • Stringent regulatory processes for drug approval
  • Market Segmentation Analysis
    • Purity: Increasing preference for >=98% purity in fluindione for meeting stringent requirements for active pharmaceutical ingredients (APIs)
    • Application: Expanding application of fluindione for anticoagulating treatment
  • Market Disruption Analysis
  • Porter's Five Forces Analysis
  • Value Chain & Critical Path Analysis
  • Pricing Analysis
  • Technology Analysis
  • Patent Analysis
  • Trade Analysis
  • Regulatory Framework Analysis

FPNV Positioning Matrix

The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Fluindione Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Fluindione Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Recent Developments

Helixomer awarded $2M NIH grant for anticoagulant development

Raleigh's Helixomer has been awarded a significant USD 2 million grant by the National Institutes of Health (NIH) for the development of innovative anticoagulant drugs. The infusion of funds from the NIH, building on prior financial backing from the North Carolina Biotechnology Center and the university's Chancellor's Innovation Fund, propels Helixomer into further preclinical development, enhancing their trajectory towards commercialization. [Published On: 2023-12-14]

Strategy Analysis & Recommendation

The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Fluindione Market. This critical assessment involves a thorough analysis of the organization's resources, capabilities, and overall performance to identify its core strengths and areas for improvement.

Key Company Profiles

The report delves into recent significant developments in the Fluindione Market, highlighting leading vendors and their innovative profiles. These include 1PlusChem LLC, Angene, Cayman Chemical Company, Clearsynth, DC Chemicals, Henan Bon Industrial Co.,Ltd., Manus Aktteva Biopharma LLP, Merck KGaA, Prime Pharmaceuticals Pvt. Ltd., Shodhana Laboratories Pvt. Ltd., TargetMol Chemicals Inc., and TEBU-BIO LIMITED.

Market Segmentation & Coverage

This research report categorizes the Fluindione Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Purity
    • 95%
    • >= 98%
  • Application
    • Anticoagulating Treatment
    • Permanent Atrial Fibrillation
    • Pulmonary Embolism
    • Venous Thrombosis
  • End-User
    • Hospitals & Clinics
    • Long-Term Care Facilities
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising cases of conditions requiring anticoagulation therapy
      • 5.1.1.2. Improvements and expansions in the global healthcare infrastructure
    • 5.1.2. Restraints
      • 5.1.2.1. Concerns related to adverse effects and interactions with other medications
    • 5.1.3. Opportunities
      • 5.1.3.1. Ongoing development of novel drug delivery systems globally
      • 5.1.3.2. Research into additional therapeutic applications of fluindione
    • 5.1.4. Challenges
      • 5.1.4.1. Stringent regulatory processes for drug approval
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Purity: Increasing preference for >=98% purity in fluindione for meeting stringent requirements for active pharmaceutical ingredients (APIs)
    • 5.2.2. Application: Expanding application of fluindione for anticoagulating treatment
  • 5.3. Market Disruption Analysis
  • 5.4. Porter's Five Forces Analysis
    • 5.4.1. Threat of New Entrants
    • 5.4.2. Threat of Substitutes
    • 5.4.3. Bargaining Power of Customers
    • 5.4.4. Bargaining Power of Suppliers
    • 5.4.5. Industry Rivalry
  • 5.5. Value Chain & Critical Path Analysis
  • 5.6. Pricing Analysis
  • 5.7. Technology Analysis
  • 5.8. Patent Analysis
  • 5.9. Trade Analysis
  • 5.10. Regulatory Framework Analysis

6. Fluindione Market, by Purity

  • 6.1. Introduction
  • 6.2. 95%
  • 6.3. >= 98%

7. Fluindione Market, by Application

  • 7.1. Introduction
  • 7.2. Anticoagulating Treatment
  • 7.3. Permanent Atrial Fibrillation
  • 7.4. Pulmonary Embolism
  • 7.5. Venous Thrombosis

8. Fluindione Market, by End-User

  • 8.1. Introduction
  • 8.2. Hospitals & Clinics
  • 8.3. Long-Term Care Facilities

9. Americas Fluindione Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Fluindione Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Fluindione Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
    • 12.3.1. Helixomer awarded $2M NIH grant for anticoagulant development
  • 12.4. Strategy Analysis & Recommendation

13. Competitive Portfolio

  • 13.1. Key Company Profiles
  • 13.2. Key Product Portfolio

LIST OF FIGURES

  • FIGURE 1. FLUINDIONE MARKET RESEARCH PROCESS
  • FIGURE 2. FLUINDIONE MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL FLUINDIONE MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL FLUINDIONE MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. GLOBAL FLUINDIONE MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. FLUINDIONE MARKET DYNAMICS
  • FIGURE 7. GLOBAL FLUINDIONE MARKET SIZE, BY PURITY, 2023 VS 2030 (%)
  • FIGURE 8. GLOBAL FLUINDIONE MARKET SIZE, BY PURITY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. GLOBAL FLUINDIONE MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 10. GLOBAL FLUINDIONE MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. GLOBAL FLUINDIONE MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 12. GLOBAL FLUINDIONE MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. AMERICAS FLUINDIONE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 14. AMERICAS FLUINDIONE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. UNITED STATES FLUINDIONE MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 16. UNITED STATES FLUINDIONE MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. ASIA-PACIFIC FLUINDIONE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 18. ASIA-PACIFIC FLUINDIONE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA FLUINDIONE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA FLUINDIONE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. FLUINDIONE MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 22. FLUINDIONE MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. FLUINDIONE MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL FLUINDIONE MARKET SIZE, 2018-2023 (USD MILLION)
  • TABLE 4. GLOBAL FLUINDIONE MARKET SIZE, 2024-2030 (USD MILLION)
  • TABLE 5. GLOBAL FLUINDIONE MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 6. GLOBAL FLUINDIONE MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 7. GLOBAL FLUINDIONE MARKET SIZE, BY PURITY, 2018-2023 (USD MILLION)
  • TABLE 8. GLOBAL FLUINDIONE MARKET SIZE, BY PURITY, 2024-2030 (USD MILLION)
  • TABLE 9. GLOBAL FLUINDIONE MARKET SIZE, BY 95%, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 10. GLOBAL FLUINDIONE MARKET SIZE, BY 95%, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 11. GLOBAL FLUINDIONE MARKET SIZE, BY >= 98%, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 12. GLOBAL FLUINDIONE MARKET SIZE, BY >= 98%, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 13. GLOBAL FLUINDIONE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 14. GLOBAL FLUINDIONE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 15. GLOBAL FLUINDIONE MARKET SIZE, BY ANTICOAGULATING TREATMENT, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 16. GLOBAL FLUINDIONE MARKET SIZE, BY ANTICOAGULATING TREATMENT, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 17. GLOBAL FLUINDIONE MARKET SIZE, BY PERMANENT ATRIAL FIBRILLATION, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 18. GLOBAL FLUINDIONE MARKET SIZE, BY PERMANENT ATRIAL FIBRILLATION, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 19. GLOBAL FLUINDIONE MARKET SIZE, BY PULMONARY EMBOLISM, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 20. GLOBAL FLUINDIONE MARKET SIZE, BY PULMONARY EMBOLISM, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 21. GLOBAL FLUINDIONE MARKET SIZE, BY VENOUS THROMBOSIS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 22. GLOBAL FLUINDIONE MARKET SIZE, BY VENOUS THROMBOSIS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 23. GLOBAL FLUINDIONE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 24. GLOBAL FLUINDIONE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 25. GLOBAL FLUINDIONE MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 26. GLOBAL FLUINDIONE MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 27. GLOBAL FLUINDIONE MARKET SIZE, BY LONG-TERM CARE FACILITIES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 28. GLOBAL FLUINDIONE MARKET SIZE, BY LONG-TERM CARE FACILITIES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 29. AMERICAS FLUINDIONE MARKET SIZE, BY PURITY, 2018-2023 (USD MILLION)
  • TABLE 30. AMERICAS FLUINDIONE MARKET SIZE, BY PURITY, 2024-2030 (USD MILLION)
  • TABLE 31. AMERICAS FLUINDIONE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 32. AMERICAS FLUINDIONE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 33. AMERICAS FLUINDIONE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 34. AMERICAS FLUINDIONE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 35. AMERICAS FLUINDIONE MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 36. AMERICAS FLUINDIONE MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 37. ARGENTINA FLUINDIONE MARKET SIZE, BY PURITY, 2018-2023 (USD MILLION)
  • TABLE 38. ARGENTINA FLUINDIONE MARKET SIZE, BY PURITY, 2024-2030 (USD MILLION)
  • TABLE 39. ARGENTINA FLUINDIONE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 40. ARGENTINA FLUINDIONE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 41. ARGENTINA FLUINDIONE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 42. ARGENTINA FLUINDIONE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 43. BRAZIL FLUINDIONE MARKET SIZE, BY PURITY, 2018-2023 (USD MILLION)
  • TABLE 44. BRAZIL FLUINDIONE MARKET SIZE, BY PURITY, 2024-2030 (USD MILLION)
  • TABLE 45. BRAZIL FLUINDIONE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 46. BRAZIL FLUINDIONE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 47. BRAZIL FLUINDIONE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 48. BRAZIL FLUINDIONE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 49. CANADA FLUINDIONE MARKET SIZE, BY PURITY, 2018-2023 (USD MILLION)
  • TABLE 50. CANADA FLUINDIONE MARKET SIZE, BY PURITY, 2024-2030 (USD MILLION)
  • TABLE 51. CANADA FLUINDIONE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 52. CANADA FLUINDIONE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 53. CANADA FLUINDIONE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 54. CANADA FLUINDIONE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 55. MEXICO FLUINDIONE MARKET SIZE, BY PURITY, 2018-2023 (USD MILLION)
  • TABLE 56. MEXICO FLUINDIONE MARKET SIZE, BY PURITY, 2024-2030 (USD MILLION)
  • TABLE 57. MEXICO FLUINDIONE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 58. MEXICO FLUINDIONE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 59. MEXICO FLUINDIONE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 60. MEXICO FLUINDIONE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 61. UNITED STATES FLUINDIONE MARKET SIZE, BY PURITY, 2018-2023 (USD MILLION)
  • TABLE 62. UNITED STATES FLUINDIONE MARKET SIZE, BY PURITY, 2024-2030 (USD MILLION)
  • TABLE 63. UNITED STATES FLUINDIONE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 64. UNITED STATES FLUINDIONE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 65. UNITED STATES FLUINDIONE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 66. UNITED STATES FLUINDIONE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 67. UNITED STATES FLUINDIONE MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
  • TABLE 68. UNITED STATES FLUINDIONE MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
  • TABLE 69. ASIA-PACIFIC FLUINDIONE MARKET SIZE, BY PURITY, 2018-2023 (USD MILLION)
  • TABLE 70. ASIA-PACIFIC FLUINDIONE MARKET SIZE, BY PURITY, 2024-2030 (USD MILLION)
  • TABLE 71. ASIA-PACIFIC FLUINDIONE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 72. ASIA-PACIFIC FLUINDIONE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 73. ASIA-PACIFIC FLUINDIONE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 74. ASIA-PACIFIC FLUINDIONE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 75. ASIA-PACIFIC FLUINDIONE MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 76. ASIA-PACIFIC FLUINDIONE MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 77. AUSTRALIA FLUINDIONE MARKET SIZE, BY PURITY, 2018-2023 (USD MILLION)
  • TABLE 78. AUSTRALIA FLUINDIONE MARKET SIZE, BY PURITY, 2024-2030 (USD MILLION)
  • TABLE 79. AUSTRALIA FLUINDIONE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 80. AUSTRALIA FLUINDIONE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 81. AUSTRALIA FLUINDIONE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 82. AUSTRALIA FLUINDIONE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 83. CHINA FLUINDIONE MARKET SIZE, BY PURITY, 2018-2023 (USD MILLION)
  • TABLE 84. CHINA FLUINDIONE MARKET SIZE, BY PURITY, 2024-2030 (USD MILLION)
  • TABLE 85. CHINA FLUINDIONE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 86. CHINA FLUINDIONE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 87. CHINA FLUINDIONE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 88. CHINA FLUINDIONE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 89. INDIA FLUINDIONE MARKET SIZE, BY PURITY, 2018-2023 (USD MILLION)
  • TABLE 90. INDIA FLUINDIONE MARKET SIZE, BY PURITY, 2024-2030 (USD MILLION)
  • TABLE 91. INDIA FLUINDIONE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 92. INDIA FLUINDIONE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 93. INDIA FLUINDIONE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 94. INDIA FLUINDIONE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 95. INDONESIA FLUINDIONE MARKET SIZE, BY PURITY, 2018-2023 (USD MILLION)
  • TABLE 96. INDONESIA FLUINDIONE MARKET SIZE, BY PURITY, 2024-2030 (USD MILLION)
  • TABLE 97. INDONESIA FLUINDIONE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 98. INDONESIA FLUINDIONE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 99. INDONESIA FLUINDIONE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 100. INDONESIA FLUINDIONE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 101. JAPAN FLUINDIONE MARKET SIZE, BY PURITY, 2018-2023 (USD MILLION)
  • TABLE 102. JAPAN FLUINDIONE MARKET SIZE, BY PURITY, 2024-2030 (USD MILLION)
  • TABLE 103. JAPAN FLUINDIONE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 104. JAPAN FLUINDIONE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 105. JAPAN FLUINDIONE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 106. JAPAN FLUINDIONE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 107. MALAYSIA FLUINDIONE MARKET SIZE, BY PURITY, 2018-2023 (USD MILLION)
  • TABLE 108. MALAYSIA FLUINDIONE MARKET SIZE, BY PURITY, 2024-2030 (USD MILLION)
  • TABLE 109. MALAYSIA FLUINDIONE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 110. MALAYSIA FLUINDIONE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 111. MALAYSIA FLUINDIONE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 112. MALAYSIA FLUINDIONE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 113. PHILIPPINES FLUINDIONE MARKET SIZE, BY PURITY, 2018-2023 (USD MILLION)
  • TABLE 114. PHILIPPINES FLUINDIONE MARKET SIZE, BY PURITY, 2024-2030 (USD MILLION)
  • TABLE 115. PHILIPPINES FLUINDIONE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 116. PHILIPPINES FLUINDIONE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 117. PHILIPPINES FLUINDIONE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 118. PHILIPPINES FLUINDIONE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 119. SINGAPORE FLUINDIONE MARKET SIZE, BY PURITY, 2018-2023 (USD MILLION)
  • TABLE 120. SINGAPORE FLUINDIONE MARKET SIZE, BY PURITY, 2024-2030 (USD MILLION)
  • TABLE 121. SINGAPORE FLUINDIONE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 122. SINGAPORE FLUINDIONE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 123. SINGAPORE FLUINDIONE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 124. SINGAPORE FLUINDIONE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 125. SOUTH KOREA FLUINDIONE MARKET SIZE, BY PURITY, 2018-2023 (USD MILLION)
  • TABLE 126. SOUTH KOREA FLUINDIONE MARKET SIZE, BY PURITY, 2024-2030 (USD MILLION)
  • TABLE 127. SOUTH KOREA FLUINDIONE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 128. SOUTH KOREA FLUINDIONE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 129. SOUTH KOREA FLUINDIONE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 130. SOUTH KOREA FLUINDIONE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 131. TAIWAN FLUINDIONE MARKET SIZE, BY PURITY, 2018-2023 (USD MILLION)
  • TABLE 132. TAIWAN FLUINDIONE MARKET SIZE, BY PURITY, 2024-2030 (USD MILLION)
  • TABLE 133. TAIWAN FLUINDIONE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 134. TAIWAN FLUINDIONE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 135. TAIWAN FLUINDIONE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 136. TAIWAN FLUINDIONE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 137. THAILAND FLUINDIONE MARKET SIZE, BY PURITY, 2018-2023 (USD MILLION)
  • TABLE 138. THAILAND FLUINDIONE MARKET SIZE, BY PURITY, 2024-2030 (USD MILLION)
  • TABLE 139. THAILAND FLUINDIONE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 140. THAILAND FLUINDIONE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 141. THAILAND FLUINDIONE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 142. THAILAND FLUINDIONE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 143. VIETNAM FLUINDIONE MARKET SIZE, BY PURITY, 2018-2023 (USD MILLION)
  • TABLE 144. VIETNAM FLUINDIONE MARKET SIZE, BY PURITY, 2024-2030 (USD MILLION)
  • TABLE 145. VIETNAM FLUINDIONE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 146. VIETNAM FLUINDIONE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 147. VIETNAM FLUINDIONE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 148. VIETNAM FLUINDIONE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 149. EUROPE, MIDDLE EAST & AFRICA FLUINDIONE MARKET SIZE, BY PURITY, 2018-2023 (USD MILLION)
  • TABLE 150. EUROPE, MIDDLE EAST & AFRICA FLUINDIONE MARKET SIZE, BY PURITY, 2024-2030 (USD MILLION)
  • TABLE 151. EUROPE, MIDDLE EAST & AFRICA FLUINDIONE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 152. EUROPE, MIDDLE EAST & AFRICA FLUINDIONE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 153. EUROPE, MIDDLE EAST & AFRICA FLUINDIONE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 154. EUROPE, MIDDLE EAST & AFRICA FLUINDIONE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 155. EUROPE, MIDDLE EAST & AFRICA FLUINDIONE MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 156. EUROPE, MIDDLE EAST & AFRICA FLUINDIONE MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 157. DENMARK FLUINDIONE MARKET SIZE, BY PURITY, 2018-2023 (USD MILLION)
  • TABLE 158. DENMARK FLUINDIONE MARKET SIZE, BY PURITY, 2024-2030 (USD MILLION)
  • TABLE 159. DENMARK FLUINDIONE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 160. DENMARK FLUINDIONE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 161. DENMARK FLUINDIONE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 162. DENMARK FLUINDIONE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 163. EGYPT FLUINDIONE MARKET SIZE, BY PURITY, 2018-2023 (USD MILLION)
  • TABLE 164. EGYPT FLUINDIONE MARKET SIZE, BY PURITY, 2024-2030 (USD MILLION)
  • TABLE 165. EGYPT FLUINDIONE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 166. EGYPT FLUINDIONE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 167. EGYPT FLUINDIONE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 168. EGYPT FLUINDIONE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 169. FINLAND FLUINDIONE MARKET SIZE, BY PURITY, 2018-2023 (USD MILLION)
  • TABLE 170. FINLAND FLUINDIONE MARKET SIZE, BY PURITY, 2024-2030 (USD MILLION)
  • TABLE 171. FINLAND FLUINDIONE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 172. FINLAND FLUINDIONE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 173. FINLAND FLUINDIONE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 174. FINLAND FLUINDIONE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 175. FRANCE FLUINDIONE MARKET SIZE, BY PURITY, 2018-2023 (USD MILLION)
  • TABLE 176. FRANCE FLUINDIONE MARKET SIZE, BY PURITY, 2024-2030 (USD MILLION)
  • TABLE 177. FRANCE FLUINDIONE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 178. FRANCE FLUINDIONE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 179. FRANCE FLUINDIONE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 180. FRANCE FLUINDIONE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 181. GERMANY FLUINDIONE MARKET SIZE, BY PURITY, 2018-2023 (USD MILLION)
  • TABLE 182. GERMANY FLUINDIONE MARKET SIZE, BY PURITY, 2024-2030 (USD MILLION)
  • TABLE 183. GERMANY FLUINDIONE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 184. GERMANY FLUINDIONE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 185. GERMANY FLUINDIONE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 186. GERMANY FLUINDIONE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 187. ISRAEL FLUINDIONE MARKET SIZE, BY PURITY, 2018-2023 (USD MILLION)
  • TABLE 188. ISRAEL FLUINDIONE MARKET SIZE, BY PURITY, 2024-2030 (USD MILLION)
  • TABLE 189. ISRAEL FLUINDIONE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 190. ISRAEL FLUINDIONE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 191. ISRAEL FLUINDIONE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 192. ISRAEL FLUINDIONE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 193. ITALY FLUINDIONE MARKET SIZE, BY PURITY, 2018-2023 (USD MILLION)
  • TABLE 194. ITALY FLUINDIONE MARKET SIZE, BY PURITY, 2024-2030 (USD MILLION)
  • TABLE 195. ITALY FLUINDIONE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 196. ITALY FLUINDIONE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 197. ITALY FLUINDIONE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 198. ITALY FLUINDIONE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 199. NETHERLANDS FLUINDIONE MARKET SIZE, BY PURITY, 2018-2023 (USD MILLION)
  • TABLE 200. NETHERLANDS FLUINDIONE MARKET SIZE, BY PURITY, 2024-2030 (USD MILLION)
  • TABLE 201. NETHERLANDS FLUINDIONE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 202. NETHERLANDS FLUINDIONE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 203. NETHERLANDS FLUINDIONE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 204. NETHERLANDS FLUINDIONE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 205. NIGERIA FLUINDIONE MARKET SIZE, BY PURITY, 2018-2023 (USD MILLION)
  • TABLE 206. NIGERIA FLUINDIONE MARKET SIZE, BY PURITY, 2024-2030 (USD MILLION)
  • TABLE 207. NIGERIA FLUINDIONE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 208. NIGERIA FLUINDIONE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 209. NIGERIA FLUINDIONE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 210. NIGERIA FLUINDIONE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 211. NORWAY FLUINDIONE MARKET SIZE, BY PURITY, 2018-2023 (USD MILLION)
  • TABLE 212. NORWAY FLUINDIONE MARKET SIZE, BY PURITY, 2024-2030 (USD MILLION)
  • TABLE 213. NORWAY FLUINDIONE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 214. NORWAY FLUINDIONE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 215. NORWAY FLUINDIONE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 216. NORWAY FLUINDIONE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 217. POLAND FLUINDIONE MARKET SIZE, BY PURITY, 2018-2023 (USD MILLION)
  • TABLE 218. POLAND FLUINDIONE MARKET SIZE, BY PURITY, 2024-2030 (USD MILLION)
  • TABLE 219. POLAND FLUINDIONE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 220. POLAND FLUINDIONE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 221. POLAND FLUINDIONE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 222. POLAND FLUINDIONE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 223. QATAR FLUINDIONE MARKET SIZE, BY PURITY, 2018-2023 (USD MILLION)
  • TABLE 224. QATAR FLUINDIONE MARKET SIZE, BY PURITY, 2024-2030 (USD MILLION)
  • TABLE 225. QATAR FLUINDIONE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 226. QATAR FLUINDIONE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 227. QATAR FLUINDIONE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 228. QATAR FLUINDIONE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 229. RUSSIA FLUINDIONE MARKET SIZE, BY PURITY, 2018-2023 (USD MILLION)
  • TABLE 230. RUSSIA FLUINDIONE MARKET SIZE, BY PURITY, 2024-2030 (USD MILLION)
  • TABLE 231. RUSSIA FLUINDIONE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 232. RUSSIA FLUINDIONE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 233. RUSSIA FLUINDIONE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 234. RUSSIA FLUINDIONE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 235. SAUDI ARABIA FLUINDIONE MARKET SIZE, BY PURITY, 2018-2023 (USD MILLION)
  • TABLE 236. SAUDI ARABIA FLUINDIONE MARKET SIZE, BY PURITY, 2024-2030 (USD MILLION)
  • TABLE 237. SAUDI ARABIA FLUINDIONE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 238. SAUDI ARABIA FLUINDIONE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 239. SAUDI ARABIA FLUINDIONE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 240. SAUDI ARABIA FLUINDIONE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 241. SOUTH AFRICA FLUINDIONE MARKET SIZE, BY PURITY, 2018-2023 (USD MILLION)
  • TABLE 242. SOUTH AFRICA FLUINDIONE MARKET SIZE, BY PURITY, 2024-2030 (USD MILLION)
  • TABLE 243. SOUTH AFRICA FLUINDIONE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 244. SOUTH AFRICA FLUINDIONE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 245. SOUTH AFRICA FLUINDIONE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 246. SOUTH AFRICA FLUINDIONE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 247. SPAIN FLUINDIONE MARKET SIZE, BY PURITY, 2018-2023 (USD MILLION)
  • TABLE 248. SPAIN FLUINDIONE MARKET SIZE, BY PURITY, 2024-2030 (USD MILLION)
  • TABLE 249. SPAIN FLUINDIONE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 250. SPAIN FLUINDIONE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 251. SPAIN FLUINDIONE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 252. SPAIN FLUINDIONE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 253. SWEDEN FLUINDIONE MARKET SIZE, BY PURITY, 2018-2023 (USD MILLION)
  • TABLE 254. SWEDEN FLUINDIONE MARKET SIZE, BY PURITY, 2024-2030 (USD MILLION)
  • TABLE 255. SWEDEN FLUINDIONE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 256. SWEDEN FLUINDIONE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 257. SWEDEN FLUINDIONE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 258. SWEDEN FLUINDIONE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 259. SWITZERLAND FLUINDIONE MARKET SIZE, BY PURITY, 2018-2023 (USD MILLION)
  • TABLE 260. SWITZERLAND FLUINDIONE MARKET SIZE, BY PURITY, 2024-2030 (USD MILLION)
  • TABLE 261. SWITZERLAND FLUINDIONE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 262. SWITZERLAND FLUINDIONE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 263. SWITZERLAND FLUINDIONE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 264. SWITZERLAND FLUINDIONE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 265. TURKEY FLUINDIONE MARKET SIZE, BY PURITY, 2018-2023 (USD MILLION)
  • TABLE 266. TURKEY FLUINDIONE MARKET SIZE, BY PURITY, 2024-2030 (USD MILLION)
  • TABLE 267. TURKEY FLUINDIONE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 268. TURKEY FLUINDIONE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 269. TURKEY FLUINDIONE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 270. TURKEY FLUINDIONE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 271. UNITED ARAB EMIRATES FLUINDIONE MARKET SIZE, BY PURITY, 2018-2023 (USD MILLION)
  • TABLE 272. UNITED ARAB EMIRATES FLUINDIONE MARKET SIZE, BY PURITY, 2024-2030 (USD MILLION)
  • TABLE 273. UNITED ARAB EMIRATES FLUINDIONE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 274. UNITED ARAB EMIRATES FLUINDIONE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 275. UNITED ARAB EMIRATES FLUINDIONE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 276. UNITED ARAB EMIRATES FLUINDIONE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 277. UNITED KINGDOM FLUINDIONE MARKET SIZE, BY PURITY, 2018-2023 (USD MILLION)
  • TABLE 278. UNITED KINGDOM FLUINDIONE MARKET SIZE, BY PURITY, 2024-2030 (USD MILLION)
  • TABLE 279. UNITED KINGDOM FLUINDIONE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 280. UNITED KINGDOM FLUINDIONE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 281. UNITED KINGDOM FLUINDIONE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 282. UNITED KINGDOM FLUINDIONE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 283. FLUINDIONE MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 284. FLUINDIONE MARKET, FPNV POSITIONING MATRIX, 2023